Lecture 11. Health Psychology and interventions to prevent or alleviate cardiovascular disease.

Slides:



Advertisements
Similar presentations
Ten years of the CHD NSF Professor Roger Boyle CBE National Director for Heart Disease and Stroke Department of Health.
Advertisements

Lectures 5 Cardiovascular Reactivity. General reading in Health Psychology To make the most of this course you should read the relevant sections in one.
Type A behaviour, hostility and CHD: Rise and fall of a good idea?
Depression, Vital Exhaustion and recurrent heart disease.
Stress, emotion and the heart. Basic Reading This course is not organised around a textbook. I shall refer primarily to material in journals. Also consult.
Lectures 4 & 5 Cardiovascular Reactivity. General reading in Health Psychology To make the most of this course you should read the relevant sections in.
Lecture 9 Type A behaviour, hostility and CHD. Lecture 8 Reading There is material on Type A and hostility in the standard texts and general papers. See.
PRIMIS Third National Conference Tuesday 1 April 2003 Birmingham HIP for CHD Jane Matthews Practice Nurse Dr. Dai Evans PRIMIS Regional Clinical Adviser.
Badtieva Viktoria professor, doctor of medicine The Russian Scientific Centre of Restorative and Resort Medicine, Moscow, Russia Physiobalneotherapy methods.
Type D, or distressed personality and CHD. A new risk factor?
Lecture 5 Cardiovascular reactivity and essential hypertension.
Depression, Vital Exhaustion and recurrent heart disease.
Stress and heart disease: a few basics and heuristic models.
Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol VA-HIT Rubins, HB, et.
00.51 Concentration Mantra Meditation EMG-Biofeedback PMR Other Meditations Relaxation Response Other Relaxation Placebo TM Effectiveness in Reducing Trait.
National Service Frameworks Dr Stephen Newell February 2002.
BY Dr. Khaled Helmy Al Mahmora Chest Hospital BY Dr. Khaled Helmy Al Mahmora Chest Hospital Treatment Of Hypertension In Diabetes.
TitleDescriptionDurationTarget Audience Diabetes Diabetes Clinic (1:1) Nurse-led clinic focussing on managing your diabetes. Pharmacist and dietitians.
Personality Types and their Relation to Pet Preference
Task Force on Diabetes and CVD (ESC and EASD) European Heart Journal 2007;28:
Living with and beyond treatment for cancer – the challenge for secondary care Nigel Acheson Medical Director Peninsula Cancer Network.
Heart and Mind Connections: Integrated Strategies for Greater Health Presentation to Senior Leadership.
Lifestyle Medicine 101 Presented by ACLM Professionals in Training Executive Board 2014.
Example of HSR project: Cardiac Counselling and Rehabilitation: RCT of Complex Interventions Marie Johnston.
Progress with the literature reviews for the CHOICE programme Chris Dickens.
Training the trainer Training of clinical psychologists for pedagogic activity Dr. Gilles Michaux Training of clinical psychologists for pedagogic activity.
December Cardiac Rehabilitation Are you or someone you know missing the benefits of Cardiac Rehabilitation?
Management of Stable Angina SIGN 96
The National Prevention Strategy and Behavioral Health Care: Prevention Is Now RADM Peter J. Delany, Ph.D., LCSW-C Substance Abuse and Mental Health Services.
Physical Disorders and Health Psychology. Psychological and Social Influences on Health Top fatal diseases no longer infectious Psychology and behavior.
By Katie, Jenny & Tawan. Intro Hypertension is a chronic medical heart condition that is most likely to be heredity High Blood pressure is cause by high.
Incremental Decrease in Clinical Endpoints Through Aggressive Lipid Lowering (IDEAL) Trial IDEAL Trial Presented at The American Heart Association Scientific.
Copyleft Clinical Trial Results. You Must Redistribute Slides HYVET Trial The Hypertension in the Very Elderly Trial (HYVET)
Aim To determine the effects of a Coversyl- based blood pressure lowering regimen on the risk of recurrent stroke among patients with a history of stroke.
WOSCOPS: West Of Scotland Coronary Prevention Study Purpose To determine whether pravastatin reduces combined incidence of nonfatal MI and death due to.
Cardiac Rehabilitation 2011 Update for Primary Care Providers Douglass A Morrison, MD, PhD Cardiac Rehabilitation, Medical Director Yakima Regional and.
1 Psychosocial Hazards. 2 Introduction In 1990, the U.S. National Institute of Occupational Safety and Health (NIOSH) declared occupational stress to.
Cardiovascular Disease Healthy Kansans 2010 Steering Committee Meeting April 22, 2005.
SPARCL Stroke Prevention by Aggressive Reduction in Cholesterol Levels trial.
LIPID: Long-term Intervention with Pravastatin in Ischemic Disease Purpose To determine whether pravastatin will reduce coronary mortality and morbidity.
ALLHAT Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial JAMA 2002;288:
In the Name of Allah Most Beneficent and Most Merciful.
Chronic Disease Management Why is this an important issue? High numbers of patients affected Effective interventions may be available Concern that there.
Heart Disease, Stroke, Cancer, & AIDS Dr. A. H. Teich Chapter 14.
Delmar Learning Copyright © 2003 Delmar Learning, a Thomson Learning company Chapter 27 Chronic Illness.
Heart Disease and Stress. Heart Disease The leading killer of Americans A major cause of disability Different forms of heart disease Some are born with.
Cardiovascular Disease Prevention Know, Understand, and Act University of Ottawa Heart Institute Division of Prevention & Rehabilitation.
European trial on reduction of cardiac events with perindopril in stable coronary artery disease Presented at European Society of Cardiology 2003 EUROPA.
Clara K. Chow, MBBS, PhD; Julie Redfern, PhD; Graham S. Hillis, MBChB, PhD; Jay Thakkar, MBBS; K arla Santo, MBBS; Maree L. Hackett, PhD; Stephen Jan,
Results of 12 month follow up in Tulppa outpatient rehabilitation program.
Improving risk factor management for patients with poorly controlled type 2 diabetes: a systematic review of non-pharmaceutical interventions in primary.
Results from ASCOT-BPLA: Anglo-Scandinavian Cardiac Outcomes Trial–Blood Pressure Lowering Arm VBWG.
Clinical Trial Results. org ILLUSTRATE Presented at the American College of Cardiology Annual Scientific Session March, 2007 Presented by Dr. Steven E.
© Continuing Medical Implementation ® …...bridging the care gap Geriovascular Prevention Optimizing Prevention of Cardiovascular Disease in the Elderly.
Date of download: 6/28/2016 From: Drug Treatment of Hypertension in the Elderly: A Meta-Analysis Ann Intern Med. 1994;121(5): doi: /
كلية العلوم الصحية بالليث
Hypertension in the Post SPRINT era
Copyright © 2011 American Medical Association. All rights reserved.
Copyright © 2000 American Medical Association. All rights reserved.
Κολπικη μαρμαρυγη σε ασθενεις με αποφρακτικη υπνικη απνοια
The Anglo Scandinavian Cardiac Outcomes Trial
The Relationship Between Mental and Physical Health
Cardiovascular Disease
The Hypertension in the Very Elderly Trial (HYVET)
الفصل الرابع بـــــــرامج التأهيل
Dr. PJ Devereaux on behalf of POISE Investigators
Exercise-Based Cardiac Rehabilitation and Improvements in Cardiorespiratory Fitness: Implications Regarding Patient Benefit  Barry A. Franklin, PhD  Mayo.
Heart Disease, Stroke, Cancer, & AIDS
Beth Wallace, BSN, RN-BC, FNP-S Fairfield University Summer 2010
Many post-MI patients are not receiving optimal therapy
Presentation transcript:

Lecture 11. Health Psychology and interventions to prevent or alleviate cardiovascular disease.

Lectures 10 & 11 Reading Usual texts. Also chapter by Krantz & Lundeman on Cardiovascular disorders in Johnston & Johnston good on interventions (& other parts of course). See also Krantz & McCeney Annual Rev Psychol : There is discussion of interventions in CHD in Schiederman, Antoni, Sabb & Ironson (2001) Health Psychology: psychosocial and biobehavioural aspects pf chronic disease management. Annual Rev Psychology, 52: Especially

Prevention Primary Modification of risk factors before disease develops Not related to stress or reactivity Secondary Arrest or reverse risk factors or disease processes when risk identified but disease may not be obvious Behavioural treatment of high blood pressure Tertiary Stop or inhibit progress of established disease CHD Type A modification (Friedman)

Patel,C,Marmot,MG,Terry,DJ,Carruthers,M,Hunt,B,Patel,M, (1985)Trial of relaxation in reducing coronary risk: four year follow up. British Medical Journal,290,1103,1106 Johnston,DW,Gold,A,Kentish,J,Smith,D,Vallance,P,Shah,D,Lea ch,G,Robinson,B,(1993) Effect of stress management on blood pressure in mild primary hypertension. British Medical Journal, 306,963,966, Schneider,RH,Staggers,F,Alexander,CN,Sheppard,W,Rainfort h,M,Kondwani,K,Smith,S,King,CG,(1995) A randomized controlled trial of stress reduction for hypertension in older African Americans. Hypertension,26,820,827

Friedman,M,Thorensen,CE,Gill,JJ,Powell,LH,Ul mer,D,Thompson,L,Price,VA,Rabin,DD,Breall,W S,Dixon,T,Levy,R,Bourg,E( 1984) Alteration of Type A behaviour and reduction in cardiac recurrences in postmyocardial infaction patients American Heart Journal,108,237,248

Recurrent Coronary Prevention Project (RCPP- Friedman & Thoresen, 1985) Questions Can Type A behaviour be reduced? Does reducing Type A reduce risk of recurrent MI Design Patients who had experienced an MI Type A Change + cardiac care (592) Cardiac care only (270) Outcomes Type Behaviour New MI

Menu (cont.) Risk factors Emotion effects of MI Recovery Period Additional investigations

Johnston M, Foulkes J, Johnston DW, Pollard B, Gudmundsdottir H. (1999) The impact on patients and partners of inpatient and extended counseling and rehabilitation: a controlled trial: Psychosomatic Med 61,